| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.06 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.32 | 0.06 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |